Latest News about 5/MeO/DMT
Recent news which mentions 5/MeO/DMT
From Benzinga
 
   GH Research: This European Biotech Company Reports Full Year 2023 Financial Results And Business Updates
   
  
  
  February 29, 2024
  From Benzinga
 From Benzinga
 
   GH Research: Steady Expenses And $229M Cash Position For 2026 Runway
   
  November 14, 2023
  Tickers 
   GHRS
  
  
  From Benzinga
 
   GH Research's Psychedelic Drug Candidate For Depression Meets FDA: Clinical Program On Hold
   
  October 02, 2023
  Tickers 
   GHRS
  
  
  From Benzinga
 
   GH Research Psychedelics Firm Q2 2023 Reports $238M Cash To Accelerate 5-MeO-DMT Programs Into 2026
   
  August 24, 2023
  Tickers 
   GHRS
  
  
  From Benzinga
 From Benzinga
 
   All On Board For 5-MeO-DMT: This Retreat Hosts Expertly Guided Experiences For Women, BIPOC
   
  
  July 02, 2023
  From Benzinga
 
   GH Research: Q1 2023 Financials And Businesses For European 5-MeO-DMT Depression Treatment Developer
   
  May 11, 2023
  Tickers 
   GHRS
  
  
  From Benzinga
 From Benzinga
 
   UK-Based Approach To Alcohol Addiction: 5-MeO-DMT Candidate Moves To Phase 2 Clinical Stage
   
  
  April 05, 2023
  From Benzinga
 From Benzinga
 
   New Sublingual Psychedelic Drug Candidate Created For Depression And Anxiety In Alzheimer's
   
  December 29, 2022
  Tickers 
   BMNDF
  
  
  From Benzinga
 From Benzinga
 
   Psychedelic Experiences: UCL Leads First-Ever Brain Imaging Study In Retreat Participants
   
  
  December 07, 2022
  From Benzinga
 
   Beyond Magic Mushrooms: Positive Clinical Trial For Treatment-Resistant Depression & Alcoholism
   
  
  November 16, 2022
  From Benzinga
 
   Psychedelics Company's $60M Series A For Startup To Develop Treatment For Mental Health Disorders
   
  
  November 02, 2022
  From Benzinga
 
   Can Psychedelics Alleviate Prolonged Grief? Austin's Dell Med School Launches Clinical Trial To Find Out
   
  
  October 18, 2022
  From Benzinga
 
   Canadian Psychedelics Firm And Queens College Develop New Transdermal Drug Delivery System
   
  September 27, 2022
  Tickers 
   BMNDF
  
  
  From Benzinga
 
   Clinical Study On DMT Inhaled Product For Treatment-Resistant Depression Completes Dosing Stage
   
  September 23, 2022
  Tickers 
   BMNDF
  
  
  From Benzinga
 
   DMT Producer PsyBio And Shrooms Grower Red Light Holland Share Their Most Recent Financial Results
   
  
  
  August 29, 2022
  From Benzinga
 
   GH Research Shares Q2 2022 Financial Results & Business Updates
   
  August 23, 2022
  Tickers 
   GHRS
  
  
  From Benzinga
 
   Inside A 5-MeO-DMT Retreat: Who Should And Shouldn't Embark On This 'Hero's Journey'
   
  February 12, 2022
  Tickers 
   DMT
  
  
  From Benzinga
 
   5 Psychedelics For Mental Health
   
  
  February 01, 2022
  From Benzinga
 
   Beckley Psytech Begins Training Therapists For Phase 2 Trial With Toad Venom, 5-MeO-DMT
   
  
  January 24, 2022
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 

